Template:Gatifloxacin: Difference between revisions
Jump to navigation
Jump to search
Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; ! style="padding: 0 5px; font-size: 100%; background:#F8F8..." |
No edit summary |
||
Line 2: | Line 2: | ||
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Gatifloxacin |{{fontcolor|#6C7B8B|Gatifloxacin}}]]''''' | ! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Gatifloxacin |{{fontcolor|#6C7B8B|Gatifloxacin}}]]''''' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left |GATIFLOXACIN<sup>®</sup>,ZYMAXID<sup>®</sup>,ZYMAR<sup>®</sup>FDA Package Insert | ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left |GATIFLOXACIN<sup>®</sup>,ZYMAXID<sup>®</sup>,ZYMAR<sup>®</sup><br>FDA Package Insert</br> | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Gatifloxacin description|Description]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Gatifloxacin description|Description]] |
Revision as of 20:48, 8 January 2014
Gatifloxacin |
---|
GATIFLOXACIN®,ZYMAXID®,ZYMAR® FDA Package Insert |
Description |
Clinical Pharmacology |
Microbiology |
Indications and Usage |
Contraindications |
Warnings |
Precautions |
Adverse Reactions |
Overdosage |
Clinical Studies |
Dosage and Administration |
How Supplied |
Medication Guide |
Direction For Use |
Labels and Packages |